Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F R Appelbaum

Showing results (391-400 of 490) with videos related to

Pageof 49
Sort By:
Blood|August 9, 2001
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicinM L Linenberger, T Hong, D Flowers, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
High-dose radioimmunotherapy of B cell lymphomasO W Press, J F Eary, C C Badger, et al.
Seminars in Hematology|January 1, 1984
Marrow transplantation for aplastic anemiaR Storb, E D Thomas, C D Buckner, et al.
Cancer Research|February 1, 1990
High dose radiolabeled antibody therapy of lymphomaI D Bernstein, J F Eary, C C Badger, et al.
Medical Physics|July 1, 1994
Post therapy imaging in high dose I-131 radioimmunotherapy patientsJ F Eary, K R Pollard, L D Durack, et al.
Blood|September 1, 1985
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host diseaseR Storb, H J Deeg, E D Thomas, et al.
Leukemia|September 30, 2005
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706M A Hussein, H Gundacker, D R Head, et al.
Bone Marrow Transplantation|December 1, 1986
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiationH J Deeg, K M Sullivan, C D Buckner, et al.
Blood|November 23, 2000
Thalidomide for treatment of patients with chronic graft-versus-host diseaseS Koc, W Leisenring, M E Flowers, et al.
Transplantation|November 1, 1992
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemiaF R Appelbaum, D C Matthews, J F Eary, et al.
Pageof 49

Showing results (391-400 of 490) with videos related to

Sort By:
Pageof 49
Blood|August 9, 2001
Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicinM L Linenberger, T Hong, D Flowers, et al.
Frontiers of Radiation Therapy and Oncology|January 1, 1990
High-dose radioimmunotherapy of B cell lymphomasO W Press, J F Eary, C C Badger, et al.
Seminars in Hematology|January 1, 1984
Marrow transplantation for aplastic anemiaR Storb, E D Thomas, C D Buckner, et al.
Cancer Research|February 1, 1990
High dose radiolabeled antibody therapy of lymphomaI D Bernstein, J F Eary, C C Badger, et al.
Medical Physics|July 1, 1994
Post therapy imaging in high dose I-131 radioimmunotherapy patientsJ F Eary, K R Pollard, L D Durack, et al.
Blood|September 1, 1985
Marrow transplantation for chronic myelocytic leukemia: a controlled trial of cyclosporine versus methotrexate for prophylaxis of graft-versus-host diseaseR Storb, H J Deeg, E D Thomas, et al.
Leukemia|September 30, 2005
Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706M A Hussein, H Gundacker, D R Head, et al.
Bone Marrow Transplantation|December 1, 1986
Marrow transplantation for acute nonlymphoblastic leukemia in first remission: toxicity and long-term follow-up of patients conditioned with single dose or fractionated total body irradiationH J Deeg, K M Sullivan, C D Buckner, et al.
Blood|November 23, 2000
Thalidomide for treatment of patients with chronic graft-versus-host diseaseS Koc, W Leisenring, M E Flowers, et al.
Transplantation|November 1, 1992
The use of radiolabeled anti-CD33 antibody to augment marrow irradiation prior to marrow transplantation for acute myelogenous leukemiaF R Appelbaum, D C Matthews, J F Eary, et al.
Pageof 49